Correction: Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer

Zhenbin Xu; Hongpeng Duan; Yuling Shi; Zixia Zhou; Zhuo Wei; Xuechen Qian; Jian Lu; Yuemingming Jiang; Feng Mao; Nianyu Xue; Shengmin Zhang

doi:10.1039/D5RA90090E

Correction: Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer

Zhenbin Xu,

^a Hongpeng Duan,

^a Yuling Shi,

^ab Zixia Zhou,

^ab Zhuo Wei,

^ab Xuechen Qian,

^a Jian Lu,

^a Yuemingming Jiang,

^a Feng Mao,

^a Nianyu Xue

^a and Shengmin Zhang

*^ab

Author affiliations

* Corresponding authors

^a Department of Ultrasonography, The First Affiliated Hospital of Ningbo University, China
E-mail: fyyzhangshengmin@nbu.edu.cn

^b Health Science Center, Ningbo University, Ningbo, China

Abstract

Correction for ‘Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer’ by Zhenbin Xu et al., RSC Adv., 2025, 15, 23136–23145, https://doi.org/10.1039/D5RA01016K.

RSC Advances

Correction: Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Ultrasound-mediated paclitaxel-loaded EGFR nanoparticles for targeted therapy in breast cancer

Social activity

Search articles by author

Spotlight

Advertisements